Loading...
Loading...
Gabelli is out with its report today on Cameco
CCJ, maintaining Buy.
In a note to clients, Gabelli writes, "Cameco is highly committed to long-term uranium contracts until 2016 which provides protection in the near term to volatile uranium spot prices post the nuclear incident in Fukushima. Cameco's collection of valuable assets and its contracting strategy place the Company in the best position to benefit in the short-term and long-term as uranium demand increases due to increased demand for nuclear power."
At the time of posting, shares of CCJ were trading at $24.51, up 0.70% from Thursday's close.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in